Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Capital Employed: 2011-2024

Historic Return on Capital Employed for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Dec 2024 value amounting to 0.25%.

  • Ironwood Pharmaceuticals' Return on Capital Employed rose 68.00% to 0.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.97%, marking a year-over-year increase of 68.00%. This contributed to the annual value of 0.25% for FY2024, which is 211.00% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.25% for FY2024, which was up 113.49% from -1.85% recorded in FY2023.
  • Ironwood Pharmaceuticals' Return on Capital Employed's 5-year high stood at 0.34% during FY2021, with a 5-year trough of -1.85% in FY2023.
  • Over the past 3 years, Ironwood Pharmaceuticals' median Return on Capital Employed value was 0.23% (recorded in 2022), while the average stood at -0.46%.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Return on Capital Employed slumped by 208bps in 2023, and later skyrocketed by 211bps in 2024.
  • Ironwood Pharmaceuticals' Return on Capital Employed (Yearly) stood at 0.32% in 2020, then climbed by 2bps to 0.34% in 2021, then dropped by 11bps to 0.23% in 2022, then crashed by 208bps to -1.85% in 2023, then surged by 211bps to 0.25% in 2024.